CROTAN Drug Patent Profile
✉ Email this page to a colleague
When do Crotan patents expire, and when can generic versions of Crotan launch?
Crotan is a drug marketed by Legacy Pharma and is included in one NDA.
The generic ingredient in CROTAN is crotamiton. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the crotamiton profile page.
Summary for CROTAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Patent Applications: | 3,166 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CROTAN |
DailyMed Link: | CROTAN at DailyMed |
US Patents and Regulatory Information for CROTAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Legacy Pharma | CROTAN | crotamiton | LOTION;TOPICAL | 087204-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |